Alpha Tau Medical Announces 2026 Annual Meeting and Proposed Executive Compensation Changes
Alpha Tau Medical Ltd. filed a Form 6-K on May 18, 2026, to announce its 2026 Annual General Meeting of Shareholders, scheduled for June 23, 2026. The meeting agenda includes six primary proposals: (1) the re-election of David Milch and Ruth Alon as Class II directors for terms expiring in 2029; (2) the re-approval of the companyβs Compensation Policy for Executive Officers and Directors; (3) the re-appointment of CEO Uzi Sofer to continue serving as Chairman of the Board; (4) the approval of a new compensation package for Uzi Sofer, including a 25% base salary increase to 204,886 NIS per month, effective January 1, 2026; (5) granting the Board authority to extend the exercise terms of certain options for directors and officers by up to ten years; and (6) the re-appointment of Kost Forer Gabbay & Kasierer as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The Board unanimously recommends shareholders vote in favor of all proposals.